M. Wright

707 total citations
9 papers, 484 citations indexed

About

M. Wright is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, M. Wright has authored 9 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in M. Wright's work include Virus-based gene therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Interference and Gene Delivery (2 papers). M. Wright is often cited by papers focused on Virus-based gene therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Interference and Gene Delivery (2 papers). M. Wright collaborates with scholars based in United States. M. Wright's co-authors include David T. Curiel, R M Conry, Albert F. LoBuglio, L A Sumerel, Richard J. Benjamin, Donghao Lu, Jessy S. Deshane, Theresa V. Strong, Gene P. Siegal and R. Pat Bucy and has published in prestigious journals such as Nucleic Acids Research, Breast Cancer Research and Treatment and Gynecologic Oncology.

In The Last Decade

M. Wright

9 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Wright United States	7	362	169	154	110	84	9	484
Derek T. Cummings Canada	10	226 0.6×	216 1.3×	209 1.4×	146 1.3×	74 0.9×	16	502
Hanna Dreja United Kingdom	13	399 1.1×	197 1.2×	438 2.8×	143 1.3×	103 1.2×	24	818
M. Kathryn Liszewski United States	11	252 0.7×	176 1.0×	67 0.4×	99 0.9×	58 0.7×	12	396
Silke Holtkamp Germany	4	363 1.0×	130 0.8×	200 1.3×	115 1.0×	91 1.1×	8	496
Susan M. Cleveland United States	13	186 0.5×	76 0.4×	128 0.8×	108 1.0×	62 0.7×	19	462
Joshua Glover United States	6	284 0.8×	126 0.7×	163 1.1×	153 1.4×	85 1.0×	7	473
Yanal Murad Canada	14	226 0.6×	108 0.6×	209 1.4×	166 1.5×	66 0.8×	26	583
Luciene Lopes United Kingdom	11	225 0.6×	212 1.3×	356 2.3×	121 1.1×	78 0.9×	13	569
I Givol United States	8	283 0.8×	106 0.6×	112 0.7×	138 1.3×	31 0.4×	10	515
Abderaouf Selmi Germany	6	374 1.0×	109 0.6×	275 1.8×	117 1.1×	58 0.7×	7	508

Countries citing papers authored by M. Wright

Since Specialization

Citations

This map shows the geographic impact of M. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wright more than expected).

Fields of papers citing papers by M. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wright. The network helps show where M. Wright may publish in the future.

Co-authorship network of co-authors of M. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wright. A scholar is included among the top collaborators of M. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wright. M. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Amarenco, G., et al.. (2012). 467 Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Preliminary results from the SONIC urodynamic study. European Urology Supplements. 11(1). e467–e467a. 4 indexed citations

2.

Chapple, Christopher R., et al.. (2006). Comparison of solifenacin 5 MG and tolterodine ER 4 mg in the star OAB study.. Neurourology and Urodynamics. 25(6). 617–617. 1 indexed citations

3.

Chapple, Christopher R., et al.. (2006). THE STAR STUDY: ANALYSIS OF SYMPTOM SEVERITY AND TREATMENT RESPONSE IN OVERACTIVE BLADDER. European Urology Supplements. 5(2). 117–117. 11 indexed citations

4.

Ruppert, J. Michael, M. Wright, Michael Rosenfeld, et al.. (1997). Gene therapy strategies for carcinoma of the breast. Breast Cancer Research and Treatment. 44(2). 93–114. 15 indexed citations

5.

Kim, Myung‐Hee, M. Wright, Jessy S. Deshane, et al.. (1997). A Novel Gene Therapy Strategy for Elimination of Prostate Carcinoma Cells from Human Bone Marrow. Human Gene Therapy. 8(2). 157–170. 25 indexed citations

6.

Wright, M., et al.. (1997). An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. Gene Therapy. 4(4). 317–322. 48 indexed citations

7.

Deshane, Jessy S., Gene P. Siegal, Minghui Wang, et al.. (1997). Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy. Gynecologic Oncology. 64(3). 378–385. 47 indexed citations

8.

Conry, R M, et al.. (1995). A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo. Nucleic Acids Research. 23(9). 1495–1501. 80 indexed citations

9.

Conry, R M, Albert F. LoBuglio, M. Wright, et al.. (1995). Characterization of a messenger RNA polynucleotide vaccine vector.. PubMed. 55(7). 1397–400. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact